Taylor Frigon Capital Management LLC Abb Vie Inc. Transaction History

Taylor Frigon Capital Management LLC

$199 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $72,751 - $84,957	-470 Reduced 4.51%	9,945 $1.71 Million
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $14,383 - $16,389	-90 Reduced 0.86%	10,415 $1.9 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $51,187 - $57,648	-372 Reduced 3.42%	10,505 $1.63 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $20,172 - $23,352	151 Added 1.41%	10,877 $1.62 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $33,922 - $42,214	-256 Reduced 2.33%	10,726 $1.45 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $52,927 - $60,953	-366 Reduced 3.23%	10,982 $1.75 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $182,292 - $218,616	-1,318 Reduced 10.41%	11,348 $1.84 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $31,405 - $36,019	-234 Reduced 1.81%	12,666 $1.7 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $27,799 - $35,341	-202 Reduced 1.54%	12,900 $1.98 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $38,670 - $47,978	-293 Reduced 2.19%	13,102 $2.12 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $20,196 - $25,554	188 Added 1.42%	13,395 $1.81 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $42,240 - $47,949	397 Added 3.1%	13,207 $1.43 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $88,271 - $98,339	839 Added 7.01%	12,810 $1.44 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $31,406 - $34,574	307 Added 2.63%	11,971 $1.3 Million
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $8,048 - $10,867	-100 Reduced 0.85%	11,664 $1.25 Million
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $8,505 - $9,982	99 Added 0.85%	11,764 $1.03 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $1,760 - $2,356	24 Added 0.21%	11,665 $1.15 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $6,966 - $10,561	-108 Reduced 0.92%	11,641 $887,000
Q4 2019 Jan 24, 2020	SELL	$72.13 - $90.25 $15,580 - $19,494	-216 Reduced 1.81%	11,749 $1.04 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $13,540 - $16,279	215 Added 1.83%	11,965 $906,000
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $5,321 - $6,802	81 Added 0.69%	11,750 $854,000
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $29,930 - $35,226	-388 Reduced 3.22%	11,669 $940,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $1,401 - $1,728	18 Added 0.15%	12,057 $1.11 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $6,757 - $7,511	76 Added 0.64%	12,039 $1.14 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $104,234 - $123,333	-1,161 Reduced 8.85%	11,963 $1.11 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $84,281 - $112,860	-916 Reduced 6.52%	13,124 $1.24 Million
Q4 2017 Jan 25, 2018	BUY	$89.56 - $98.21 $1.26 Million - $1.38 Million	14,040	14,040 $1.36 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.

Account